AnalystsInsight

David Perry (J.P. Morgan): Analyst Track Record and Price‑Target Accuracy

How often David Perry’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 2 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • David Perry ranks #687 of 1,000 analysts in Exent’s scoring (4.7★).
  • 100.0% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 166 days; 0.0% of calls were up 12 months later.
  • Most‑covered stocks: ETR-RHM, EPA-AIR, ETR-R3NK, ETR-HAG.
  • Free on Exent: David Perry’s full record, with ratings 3 days after publication.

David Perry’s track record at a glance

David Perry of J.P. Morgan ranks #687 of the 1,000 analysts Exent scores, with a 4.7★ rating and a focus on industrials. Over a 7‑year lookback, 100.0% of David’s price targets were reached, 47.6 points above the 52.4% average across all analysts.

MetricDavid PerryAll analysts
Price‑target hit rate100.0%52.4%
Median days to hit target166 days91 days
Calls up after 12 months0.0%64.0%
Median 12‑month return of calls−1.7%+13.4%
Hit rate, last 2 years——
Average worst drop after a call−16.5%—
Ratings in the sample2—
Stocks covered25—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetDavid Perry
Under 30 days0.0%
30–90 days0.0%
90–180 days100.0%
Over 180 days0.0%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks David Perry covers most

StockRatings in the sample
ETR-RHM73
EPA-AIR50
ETR-R3NK49
ETR-HAG46
ETR-MTX35
LON-BAB27
EPA-SAF23
BIT-LDO22

In the past year David’s ratings were 84% Buy, 14% Hold and 1% Sell.

David Perry’s latest ratings

DateStockActionRatingPrice target
Sep 10, 2026ETR-MTXReiterated: BuyBuy$0.00
Sep 10, 2026ETR-RHMReiterated: HoldHold$0.00
Sep 10, 2026EPA-SAFReiterated: BuyBuy$460.00
Aug 24, 2026ETR-MTXReiterated: BuyBuy$465.00
Aug 18, 2026ETR-R3NKReiterated: BuyBuy$75.00
Aug 17, 2026ETR-RHMReiterated: HoldHold$1350.00
Aug 7, 2026ETR-OHBInitiated Coverage: BuyBuy$300.00
Aug 6, 2026ETR-HAGReiterated: HoldHold$100.00
Aug 6, 2026ETR-R3NKReiterated: BuyBuy$75.00
Aug 6, 2026ETR-RHMReiterated: HoldHold$1350.00
Aug 6, 2026BIT-LDOReiterated: BuyBuy$73.00
Aug 4, 2026EPA-EXENSReiterated: BuyBuy$73.00
  • Sep 10, 2026
    Stock
    ETR-MTX
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $0.00
  • Sep 10, 2026
    Stock
    ETR-RHM
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $0.00
  • Sep 10, 2026
    Stock
    EPA-SAF
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $460.00
  • Aug 24, 2026
    Stock
    ETR-MTX
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $465.00
  • Aug 18, 2026
    Stock
    ETR-R3NK
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $75.00
  • Aug 17, 2026
    Stock
    ETR-RHM
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $1350.00
  • Aug 7, 2026
    Stock
    ETR-OHB
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $300.00
  • Aug 6, 2026
    Stock
    ETR-HAG
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $100.00
  • Aug 6, 2026
    Stock
    ETR-R3NK
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $75.00
  • Aug 6, 2026
    Stock
    ETR-RHM
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $1350.00
  • Aug 6, 2026
    Stock
    BIT-LDO
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $73.00
  • Aug 4, 2026
    Stock
    EPA-EXENS
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $73.00

David’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows David Perry’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring David Perry ranks #687 of 1,000 with a 4.7★ rating. 100.0% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 0.0% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

David Perry’s success rate is 56.4% by the ranking source and 100.0% by Exent’s price-target hit-rate backtest, with a median of 166 days to reach a target.

David Perry (J.P. Morgan) covers 25 stocks, mostly in industrials. The most frequently rated are ETR-RHM, EPA-AIR, ETR-R3NK, ETR-HAG, ETR-MTX.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.